Project Number 5P51RR000165-48 Agency/Funding Organization NCRR Funding Year 2008 View Full Project Details for TRANSGENIC EXPRESSION OF TAU AND APP IN MODELS OF ALZHEIMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category F. Research Resources 5. Infrastructure Researcher and Organization Principal Investigator WALKER, LARY C Principal Investigator First Name LARY C Principal Investigator Last Name WALKER Awardee Organization EMORY UNIVERSITY Awardee State Georgia Contact PI Country United States Project Detail FY Overall Cost $35,600 Funding Organization Agency/Funding Organization NCRR Funding Organization Country United States Related Resources Repository [AlzPED] Reduced Alzheimer’s disease pathology by St. John’s wort treatment is independent of hyperforin and facilitated by ABCC1 and microglia activation in mice
